Brassinosteroids (BRs) are plant steroids essential for normal growth and development and can be defined as steroids that carry an oxygen moiety at C-3 and additional ones at one or more of the C-2, C-6, C-22 and C-23 carbon atoms. BR biosynthesis and metabolism mutants have been obtained and the corresponding genes cloned. These include genes encoding 5= = = =-reductase and cytochrome P450 enzymes, that are similar to enzymes associated with mammalian steroid synthesis. Perception and/or response mutants have also been identified via screening for altered sensitivity to BRs. Some of these mutants have been found to be defective in a leucine-rich repeat receptor kinase and in a component of a vacuolar ATPase. This review highlights the recent advances in unraveling BR synthesis/ metabolism, transport, perception and response through the analysis of BR mutants.
Introduction
The seminal discovery in research of plant steroid hormones, generically called brassinosteroids (BRs), was the detection of growth promoting activity in an extract of rape pollen (Mitchell et al. 1970) . The eventual isolation of the most bioactive compound brassinolide (BL) (Grove et al. 1979) led to the search for related low concentration BRs in other plants. Initial experiments using BRs focused on plant responses to exogenously applied hormone including stem elongation, leaf unrolling, microtubule re-orientation and ATPase activity.
The more recent breakthrough in BR research came from the observation that the dwarf and de-etiolated phenotypes of certain Arabidopsis mutants could be rescued by the application of BRs (Li et al. 1996 . In a short space of time there has been a phenomenal increase in knowledge concerning BRs as noted by many recent reviews (Hooley 1996 , Yokota 1997 , Ecker 1997 , Clouse and Sasse 1998 , Altmann 1998a , Altmann 1998b , Altmann 1999 , Li and Chory 1999 . This rapid advance has been primarily due to the synthesis of BR biosynthetic intermediates and the availability of mutants with defective BR biosynthesis/metabolism or signaling. This review highlights the major discoveries in BR research with a focus on the mutants that have helped unravel BR biosynthesis, metabolism, signaling and response processes.
Biosynthesis of BRs
The generic term BR was allocated to growth-promoting plant steroids by Mandava (1988) . However, various BR biosynthetic intermediates have been identified which raise the question of the exact location of the boundary between sterols and BRs. To clarify this situation we propose that BRs be defined as steroids that have an oxygen moiety at C-3 and additional ones at one or more of the C-2, C-6, C-22 and C-23 carbon atoms (steroid numbering system is given in Fig. 1 ).
Lesions in sterol or BR biosynthesis give rise to dwarf mutants that exhibit pleiotropy with dark green epinastic leaves in light and, when grown in darkness, do not become fully etiolated. This typical phenotype of BR deficiency was recently substantiated by applying brassinazole, a BR biosynthesis inhibitor, to cucumber, cress and mung bean Yoshida 1999, Asami et al. 2000) .
A number of sterol biosynthesis mutants that are BRdeficient have been isolated (Fig. 2) . The fackel (fk) mutant of Arabidopsis has recently been shown to lack C-14 sterol reductase activity (Jang et al. 2000 , Schrick et al. 2000 . In contrast to other sterol mutants the fk mutant phenotype cannot be rescued by BR application and is therefore likely to be the consequence of both reduced endogenous BR levels and altered sterol compositions essential for normal cell development. Mutants involved in the three consecutive reactions from episterol to campesterol have been isolated from Arabidopsis. The three alleles dwarf1 (dwf1), diminuto (dim) (Takahashi et al. 1995 , Klahre et al. 1998 ) and cabbage1 (cbb1) are defective in the synthesis of campesterol from 24-methylenecholesterol and lkb is the equivalent mutant in pea (Nomura et al. 1997 . The ste1 and dwarf7 (dwf7) are alleles that are defective in the dehydrogenation of episterol to 5-dehydroepisterol while dwarf5 (dwf5) is defective in the reduction of 5-dehydroepisterol to 24-methylenecholesterol. deetiolated2 (det2) and its allele dwarf6 (dwf6) are mutants in a 5=-steroid reductase (Li et al. 1996 that links campesterol to campestanol by catalyzing the conversion of (24R)-24-methylcholest-4-en-3-one to (24R)-24-methyl-5=-cholestan-3-one (Fujioka et al. 1997) . Phenotypic rescue experiments of the sax1 mutation using synthetic BRs suggest that sax1 is involved in the conversion of 3>,22-dihydroxyl-, 5 precursors to 3-oxo-22-hydroxy-, 4 steroids (Ephritikhine et al. 1999b) .
The synthesis of BL, a C 28 BR, starts at the conversion of campestanol via either the early or late C-6 oxidation pathway, depending on whether BRs have a ketone group (the former) or a deoxo form (the latter) at the C-6 position (Fig. 2) . These parallel pathways converge at castasterone (CS), the immediate precursor of BL (Fig. 2) . The late C-6 oxidation pathway is more prevalent in a number of species including Arabidopsis and pea (Nomura et al. 2001) , while in tomato it appears to be the sole route to BR production. Recently a cross-linked pathway from 6-deoxotyphasterol to typhasterol was demonstrated (Fig. 2) .
To date, all BR biosynthesis mutants have defects in cytochrome P450 monooxygenases (P450s or CYPs). The Arabidopsis dwarf4 (dwf4) (Choe et al. 1998) , constitutive photomorphogenesis and dwarfism (cpd) mutants are, through phenotypic rescue experiments using BR intermediates, thought to be blocked in the hydroxylation of C-22 and C-23, respectively. The tomato mutant dumpy (dpy) has been suggested to be the equivalent of cpd (Koka et al. 2000) . The dwarf (d) mutant of tomato represents a new locus (Bishop et al. 1996 , Bishop et al. 1999 ) with the Dwarf gene (D) encoding a P450 that has been classified as CYP85 with high homology to CPD and DWF4. DWARF has been shown to catalyze the conversion of 6-deoxocastasterone to castasterone via the hydroxylated form of 6-deoxocastasterone which is the key step linking the late C-6 oxidation pathway to the early C-6 oxidation pathway (Bishop et al. 1999) . In tomato BL has not yet been detected and it has been suggested that castasterone may be the most active BR in this species (Yokota 1997 , Bishop et al. 1999 . No Arabidopsis mutant has been isolated equivalent to the mutation at the tomato Dwarf locus. However the genomic and cDNA sequences of the putative Arabidopsis homolog of Dwarf CYP85A have been determined (G. Bishop, unpublished) .
Regulation of BR levels
The available evidence indicates that plant hormones are in a state of flux, undergoing continual turnover. To maintain effective hormone concentrations there needs to be a balance between the rates of biosynthesis and metabolism or inactivation. Little is known of the regulation of BR biosynthesis or of the mechanism of inactivation. Current studies of transgenic lines harboring the CPD promoter fused to the >-glucuronidase (GUS) reporter gene indicate that this gene is expressed in confined regions of the shoots but seemingly not in roots (Mathur et al. 1998 ). CPD expression has been shown to be negatively regulated by exogenously applied BRs (Mathur et al. 1998 ) similar to that reported for expression of genes involved in the biosynthesis of gibberellins (Chiang et al. 1995 , Phillips et al. 1995 , Xu et al. 1995 , Cowling et al. 1998 ). This suggests a mechanism for autoregulation of hormone levels. In a transgenic tomato harboring the D promoter fused to >-glucuronidase the D gene is specifically expressed in root tips and shoot apex, indicating that the transcriptional regulation of this gene may control the synthesis of CS from 6-deoxoCS and play an important role in growth and development (G. Bishop, unpublished) . As discussed later D activity seems to be affected by BR signaling.
In addition to BR synthesis, BR metabolism is also controlled. BR metabolism has been studied by feeding 24-epibrassinolide to tomato suspension cultures resulting in the identification of both C-25 hydroxylated and C-26 hydroxylated derivatives (Kolbe et al. 1996) . In this experiment C-25 hydroxylation was thought to be a P450 catalyzed reaction and C-26 hydroxylation not. Conversely enhancer tagging that effects the ectopic overexpression of a cytochrome P450 (CYP72B1) generates the bas1-D mutant with stunted phenotype characteristic of BR mutants. This dominant mutant is deficient in biologically active BRs such as CS and BL and exhibits enhanced C-26 hydroxylation of exogenous BL (Neff et al. 1999) . It remains an open question as to whether CYP72B1 represents the bona fide inactivating enzyme of BL biosynthesis or whether this is consequence of a non-specific xenobiotic detoxification type reaction. A similar cytochrome P450 (CYP72C1) was identified from the Arabidopsis BRdeficient mutant chibi2 generated by activation T-DNA tag- ging (Nagatani et al. 1998, Nagatani private communication) . A sulfotransferase gene in Brassica napus is involved in sulfonation of the C-22 hydroxyl, thereby deactivating BRs (Rouleau et al. 1999) . However, it is puzzling that this enzyme action is specific for 24-epimers, which are probably quite minor BRs in B. napus.
BR transport
One of the conceptual problems with plant hormones is the argument that a hormone is a substance that is synthesized by an endocrine organ and the hormone is transported and perceived by other tissues. This definition derived from animals that have an efficient circulatory system is not easily translated to plants and their vascular system. Generally plant hormone synthesis and action may take place in different locations. However, similar to synthesis and action of some autacoids, e.g. prostaglandins, to a small-restricted area and steroidal hormone synthesis in the brain, BRs may be synthesized close to the site of action. The incomplete restoration to a normal phenotype of the tomato d
x mutant was suggestive of poor transport of BRs (Bishop et al. 1999 ). In addition the recovery of transposon sectored plants (Bishop et al. 1996) suggest that endogenously synthesized BRs may have more localized effects. In support of this, grafting experiments using lka and lkb mutants indicate at least no acropetal transport of BRs in pea shoots (Reid and Ross 1989) . However, evidence from root application of radiolabeled steroid hormones in tomato, rice, cucumber and wheat suggests that BRs are transported acropetally (Schlagnhaufer and Arteca 1991 , Yokota et al. 1992 , Nishikawa et al. 1994 ). Leaf-treated BRs are less readily transported: most radioactivity is confined within treated leaves in rice and wheat but slowly moves out from the treated leaves in cucumber. Further studies into BR movement will help to clarify potential inconsistencies between grafting and exogenous application of BRs.
Perception and BRI
In mammalian cells steroidal hormones interact with steroid nuclear receptors, which leads to the promotion of transcription of specific target genes, commonly referred to as genomic signaling. In addition steroids can have direct effects on cellular processes termed non-genomic signaling as reviewed by Wehling (1997) . In plants no obvious homologs of nuclear steroid receptors are known and components of BR signaling may have equivalent counterparts in mammalian nongenomic signaling. To identify components of the BR signaling pathway a genetic approach was adopted by identifying mutants that are insensitive to exogenously applied BRs. The Arabidopsis mutant brassinolide insensitive1 (bri1) was the first BL insensitive mutant to be identified by its ability for root elongation in the presence of BL (Clouse et al. 1996) . BRI1 was cloned, sequenced and predicted to encode a leucinerich repeat receptor kinase (LRRRK) . LRRRKs are crucial for many plant signaling processes such as disease resistance (Song et al. 1995) , plant architecture (Torii et al. 1996) , flower abscission (Jinn et al. 2000) and meristem proliferation (Clark et al. 1997) .
Recently there have been rapid advances in the study of the clavata (clv) mutants, which provide tantalizing ideas how BRI1 may function in BR signaling. The clv mutants 1, 2 and 3 are defective in normal meristem proliferation. CLAVATA1 (CLV1) encodes an LRRRK (Clark et al. 1997 ) that forms a complex with KAPP (kinase-associated protein phosphatase) and a Rho GTPase-related protein ). CLV3 acts to promote this complex formation and is a small cysteine-rich secreted protein. CLV2 is a receptor-like protein (RLP) which most probably interacts with CLV1 as a heterodimer, possibly via transmembrane charge (Jeong et al. 1999) . If this were a paradigm for LRRRK interactions it would suggest that BRI1 interacts with an RLP and a small secreted protein ligand which may be steroid binding. Furthermore, the genetic evidence that bri heterozygotes are not semidominant also suggests that BRI1 protein is unlikely to operate as a homodimer.
A ground-breaking experiment has shown that the LRR region is sufficient for sensing BL (He et al. 2000) . In this experiment the BRI1 LRR region was fused to the kinase domain of the disease resistance gene Xa21 from rice. Transgenic rice cells harboring this fusion respond to BL application by inducing plant defense responses similar to those observed in Xa21 rice cells. This would imply that components of any BL receptor complex are conserved between rice and Arabidopsis. The recently cloned rice homolog of BRI1 as well as associated dwarf mutants will help to unravel this conservation of function between rice and Arabidopsis (Yamamuro et al. 2000) . There is still an open question, however, as to whether BL binds to BRI1 directly or binds to another protein that would act similar to CLV3 protein prior to interacting with BRI1.
Another important feature of BRI1 is that it is a plasma membrane-localized protein acting Ser/Thr phosphorylation, suggesting that BRs are perceived at the cell surface (Friedrichsen et al. 2000) . They also found that BRI1 is expressed in all tissues but at lower levels in older ones, coinciding with the fact that only younger tissues are sensitive to BRs.
Interestingly endogenous BR concentrations are increased in the different bri1 alleles with the most severe alleles having the highest concentration BRs ). This indicates that BRI1 plays a part in the homeostasis of BR levels. In addition the pea mutant lka has also been shown to be BL insensitive and has increased levels of endogenous BRs (Nomura et al. 1997) . Similarly tomato mutant curl-3 (cu-3) has been shown to be BR insensitive (Koka et al. 2000) and cu-3 has increased levels of castasterone (T. Nomura, T. Yokota and G. Bishop, unpublished results) . This suggests that lka and cu-3 could be equivalent mutations to bri and cloning the homolog of BRI1 from these mutants will be very informative.
BR response
In many cases plants show a similar response to exogenous application of auxin and BRs and care needs to be taken to discern BR specific responses. Initially one BR upregulated gene BRU1 was cloned from soybean and found to encode a xyloglucan endotransferase (XET) (Zurek and Clouse 1994) . XETs are enzymes that are most likely involved in cell wall loosening and such genes therefore provide a direct link between BRs and an induced growth response. The Arabidopsis and rice XET-related genes have also been found to be upregulated by BRs (Xu et al. 1996 , Klahre et al. 1998 , Uozu et al. 2000 . A tomato XET has also been isolated based on its up regulation by BRs (Koka et al. 2000) .
The direction of plant cell expansion is regulated by the orientation of cellulose microfibrils in the cell wall. This, in turn, is controlled by the orientation of cortical microtubules. BRs have been shown to promote a transverse orientation of microtubules thereby accelerating cell elongation (Mayumi and Shibaoka 1995) . Microtubles are composed of a heterodimer formed by =-and >-tubulin polypeptide with microtubuleassociated proteins (MAPs). Recently it was found that BLinduced growth is accompanied by the expression of a putative >-tubulin gene in Cicer arietinum (Munoz et al. 1998) . This is in accord with the early finding that the expression of a >-tubulin gene, TUB1, is suppressed in the BR-deficient mutant dim (dwf1) (Takahashi et al. 1995) .
A novel cDNA tentatively named BR-upregulated gene 2 (BRU2) that may encode an actin effector protein that controls polymerization of actin molecules was isolated from rice seedlings treated with BL (Sasuga et al. 2000) . Actin is associated with microtubules to determine their orientation so that BRs seem to regulate the orientation of microtubules by promoting the synthesis of both an actin effector protein and >-tubulin. In accordance with this observation, BRs are synthesized immediately prior to secondary cell wall formation and cell death during tracheary element development (Yamamoto et al. 1997 , Yamamoto et al. 2000 . When the synthesis of BRs is blocked by a trizaole, uniconazole, not only secondary wall formation but also preceding actin filament aggregation and microtubule bundling are inhibited (Iwasaki and Shibaoka 1991) .
Exciting results have also been obtained from the cloning of the DET3 gene of Arabidopsis. This mutation has a phenotype similar to the BR dwarfs and initially was reported not to respond to exogenous BL . This suggested that DET3 could be a component of the BR signaling pathway. Surprisingly DET3 was found to encode a subunit of a vacuolar ATPase and the det3 mutation, although producing a normal protein, had a reduced transcript level of 50% of wild type (Schumacher et al. 1999 ). An interesting observation was that hypocotyls of the det3 mutant responded to BL when given a negative gravitropic stimulus (Schumacher et al. 1999) . This again suggests the overlapping functions of BRs and auxins in plant growth and development and the det3 mutation may provide a tool to unravel these complex interactions.
Recent evidence suggests that transcription of CDC2b, a cyclin dependent kinase, is upregulated by BRs in darkness but not in light (Yoshizumi et al. 1999 ). This suggests a mechanism for BR regulation of the cell cycle, however, more detailed analysis will be required to elucidate the role of BRs in cell division. BRs may also control source/sink relationships in tomato as BL has been shown to induce the mRNA of an intracellular invertase (Goetz et al. 2000) .
What's going to come to light?
Kinase cascades-Already much interest has been placed on putative interacting partners of the BRI kinase including KAPP and other LRRRKs including those involved in disease resistance (Koncz 1998) . Proteins that interact with BRI include subunit H of the vacuolar ATPase suggesting this could be a downstream target of BR-mediated cell expansion. Identification of further in vivo binding partners to the kinase domain may be identified through one or more of the following techniques: interaction cloning, yeast two hybrid and immuno-precipitation of receptor complexes. In addition possible interactive partners may be obtained from suppressor screens of the biosynthesis mutants. Another possible method of identifying proteins that interact with BRI kinase is to define BRI kinase substrate specificity. The consensus sequence surrounding the phosphorylated serine or threonine residues could then be used to discern putative interacting proteins via database searches. Oh et al. (2000) used such a method and have identified a putative BRI kinase consensus phosphorylation sequence in vitro. Database searches have identified several Arabidopsis proteins with such a consensus sequence, including many proteins with roles in signal transduction pathways. Further work is underway to determine if these proteins are true interacting partners of the BRI1 kinase domain in vivo. It is apparent that the kinase interacting partners discerned from any of the above methods will provide the putative insights to the downstream responses of BRs and also crosstalk mechanisms.
The role of BRs in light regulated development-One of the important areas to be addressed will be the dissection of the interactions between light and BR biosynthesis and/or BR signaling processes. The observation that BR mutants have a deetiolated phenotype suggests that BRs play an important role in the transmission of light signals. It remains to be determined whether there is a direct link between signaling pathways of light and BRs or whether de-etiolation is the consequence of the dwarfism. Currently, it is an intriguing subject to investigate with the key question of whether the quality and quantity of light alters BR levels via regulation of BR biosynthesis genes. The expression of these genes in the well-characterized light photoreceptor and signaling mutants will provide further information as to the potential transcriptional regulation of BR biosynthesis. However, to this end, characterization of some BR biosynthetic genes that have not yet been cloned is required for such analysis in order to make meaningful conclusions. One of these is the key gene involved in the lactone introduction into the B ring that converts castasterone to brassinolide. The isolation of this gene and associated mutants will also clarify whether precursors of BL like CS are bioactive or whether BL is the only bioactive BR.
In addition to the transcriptional regulation, a detailed analysis of double and triple mutants may reveal direct crosstalk between BR and light induced kinase signaling pathways.
Interaction of BRs with other plant hormones-The biological activities of BRs sometimes resemble those of auxin, ethylene or gibberellins. In particular, interactions between auxin and BRs have been discussed. Mandava (1988) , Sakurai and Fujioka (1993) , Yokota (1997) and recently Kim et al. (2000) demonstrated that BRs are involved in root gravitropism in an IAA-dependent manner. BRs also affect the biosynthesis of other hormones and the enhanced ethylene production by BRs has been well documented (Mandava 1988, Sakurai and Fujioka 1993) . Interestingly 12-oxophytodienoate reductase 3 involved in jasmonate biosynthesis is upregulated by BRs, suggesting a relationship between BRs and jasmonate signaling (Schaller et al. 2000) . It should be noted that some sterol/BR mutations were recovered from genetic screens for other hormones, e.g. the fk mutant was observed in a screen for cytokinin mutants (Jang et al. 2000) and the sax1 mutation in a screen for ABA/auxin mutants (Ephritikhine et al. 1999a) . Overall this indicates that there will be much profit in using the BR and other hormone mutants in order to dissect the interactions of hormone response.
